Down	B:C0013081
-	I:C0013081
Regulation	I:C0013081
of	O
the	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
Coupled	O
Creatine	O
Transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
by	O
Glycogen	O
Synthase	I:C0244988
Kinase	I:C0244988
GSK3	O
ß	I:C0244988

Down	O
-	I:C0013081
Regulation	I:C0013081
of	O
the	O
Na+	B:C0037494
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
Coupled	O
Creatine	O
Transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
by	O
Glycogen	O
Synthase	I:C0244988
Kinase	I:C0244988
GSK3	O
ß	I:C0244988

Down	O
-	I:C0013081
Regulation	I:C0013081
of	O
the	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
Coupled	O
Creatine	B:C0215223
Transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
by	O
Glycogen	O
Synthase	I:C0244988
Kinase	I:C0244988
GSK3	O
ß	I:C0244988

Down	O
-	I:C0013081
Regulation	I:C0013081
of	O
the	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
Coupled	O
Creatine	O
Transporter	I:C0215223
CreaT	B:C0215223
(	O
SLC6A8	O
)	O
by	O
Glycogen	O
Synthase	I:C0244988
Kinase	I:C0244988
GSK3	O
ß	I:C0244988

Down	O
-	I:C0013081
Regulation	I:C0013081
of	O
the	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
Coupled	O
Creatine	O
Transporter	I:C0215223
CreaT	O
(	O
SLC6A8	B:C0527593
)	O
by	O
Glycogen	O
Synthase	I:C0244988
Kinase	I:C0244988
GSK3	O
ß	I:C0244988

Down	O
-	I:C0013081
Regulation	I:C0013081
of	O
the	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
Coupled	O
Creatine	O
Transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
by	O
Glycogen	B:C0244988
Synthase	I:C0244988
Kinase	I:C0244988
GSK3	O
ß	I:C0244988

Down	O
-	I:C0013081
Regulation	I:C0013081
of	O
the	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
Coupled	O
Creatine	O
Transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
by	O
Glycogen	O
Synthase	I:C0244988
Kinase	I:C0244988
GSK3	B:C0244988
ß	I:C0244988

The	O
Na+	B:C0037494
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
coupled	O
creatine	O
transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
is	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
the	O
brain	O
.	O

The	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
coupled	O
creatine	B:C0215223
transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
is	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
the	O
brain	O
.	O

The	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
coupled	O
creatine	O
transporter	I:C0215223
CreaT	B:C0215223
(	O
SLC6A8	O
)	O
is	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
the	O
brain	O
.	O

The	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
coupled	O
creatine	O
transporter	I:C0215223
CreaT	O
(	O
SLC6A8	B:C0527593
)	O
is	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
the	O
brain	O
.	O

The	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
coupled	O
creatine	O
transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
is	O
expressed	B:C1171362
in	O
a	O
variety	O
of	O
tissues	O
including	O
the	O
brain	O
.	O

The	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
coupled	O
creatine	O
transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
is	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	B:C0040300
including	O
the	O
brain	O
.	O

The	O
Na+	O
,	I:C0037494
Cl	I:C0037494
-	I:C0037494
coupled	O
creatine	O
transporter	I:C0215223
CreaT	O
(	O
SLC6A8	O
)	O
is	O
expressed	O
in	O
a	O
variety	O
of	O
tissues	O
including	O
the	O
brain	B:C0006104
.	O

Genetic	O
defects	O
of	O
CreaT	B:C0215223
lead	O
to	O
mental	O
retardation	I:C0025362
with	O
seizures	O
.	O

Genetic	O
defects	O
of	O
CreaT	O
lead	O
to	O
mental	B:C0025362
retardation	I:C0025362
with	O
seizures	O
.	O

Genetic	O
defects	O
of	O
CreaT	O
lead	O
to	O
mental	O
retardation	I:C0025362
with	O
seizures	B:C0036572
.	O

The	O
present	O
study	B:C2603343
explored	O
the	O
regulation	O
of	O
CreaT	O
by	O
the	O
ubiquitously	O
expressed	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	O
,	O
which	O
contributes	O
to	O
the	O
regulation	O
of	O
neuroexcitation	O
.	O

The	O
present	O
study	O
explored	O
the	O
regulation	B:C1327622
of	O
CreaT	O
by	O
the	O
ubiquitously	O
expressed	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	O
,	O
which	O
contributes	O
to	O
the	O
regulation	O
of	O
neuroexcitation	O
.	O

The	O
present	O
study	O
explored	O
the	O
regulation	O
of	O
CreaT	B:C0215223
by	O
the	O
ubiquitously	O
expressed	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	O
,	O
which	O
contributes	O
to	O
the	O
regulation	O
of	O
neuroexcitation	O
.	O

The	O
present	O
study	O
explored	O
the	O
regulation	O
of	O
CreaT	O
by	O
the	O
ubiquitously	O
expressed	B:C1171362
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	O
,	O
which	O
contributes	O
to	O
the	O
regulation	O
of	O
neuroexcitation	O
.	O

The	O
present	O
study	O
explored	O
the	O
regulation	O
of	O
CreaT	O
by	O
the	O
ubiquitously	O
expressed	O
glycogen	B:C0244988
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	O
,	O
which	O
contributes	O
to	O
the	O
regulation	O
of	O
neuroexcitation	O
.	O

The	O
present	O
study	O
explored	O
the	O
regulation	O
of	O
CreaT	O
by	O
the	O
ubiquitously	O
expressed	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	B:C0244988
,	O
which	O
contributes	O
to	O
the	O
regulation	O
of	O
neuroexcitation	O
.	O

The	O
present	O
study	O
explored	O
the	O
regulation	O
of	O
CreaT	O
by	O
the	O
ubiquitously	O
expressed	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	O
,	O
which	O
contributes	O
to	O
the	O
regulation	B:C1327622
of	O
neuroexcitation	O
.	O

The	O
present	O
study	O
explored	O
the	O
regulation	O
of	O
CreaT	O
by	O
the	O
ubiquitously	O
expressed	O
glycogen	O
synthase	I:C0244988
kinase	I:C0244988
GSK3ß	O
,	O
which	O
contributes	O
to	O
the	O
regulation	O
of	O
neuroexcitation	B:C0234073
.	O

GSK3ß	B:C0244988
is	O
phosphorylated	O
and	O
thus	O
inhibited	O
by	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
is	O
phosphorylated	B:C0031715
and	O
thus	O
inhibited	O
by	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
is	O
phosphorylated	O
and	O
thus	O
inhibited	O
by	O
PKB	B:C0285558
/	I:C0285558
Akt	I:C0285558
.	O

Moreover	O
,	O
GSK3ß	B:C0244988
is	O
inhibited	O
by	O
the	O
antidepressant	O
lithium	O
.	O

Moreover	O
,	O
GSK3ß	O
is	O
inhibited	O
by	O
the	O
antidepressant	B:C0003289
lithium	O
.	O

Moreover	O
,	O
GSK3ß	O
is	O
inhibited	O
by	O
the	O
antidepressant	O
lithium	B:C0023870
.	O

The	O
present	O
study	B:C2603343
thus	O
further	O
tested	O
for	O
the	O
effects	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
and	O
of	O
lithium	O
.	O

The	O
present	O
study	O
thus	O
further	O
tested	O
for	O
the	O
effects	O
of	O
PKB	B:C0285558
/	I:C0285558
Akt	I:C0285558
and	O
of	O
lithium	O
.	O

The	O
present	O
study	O
thus	O
further	O
tested	O
for	O
the	O
effects	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
and	O
of	O
lithium	B:C0023870
.	O

CreaT	B:C0215223
was	O
expressed	O
in	O
Xenopus	O
laevis	I:C0043343
oocytes	O
with	O
or	O
without	O
wild	O
-	I:C1883559
type	I:C1883559
GSK3ß	O
or	O
inactive	O
K85RGSK3ß	I:C0244988
.	O

CreaT	O
was	O
expressed	B:C1171362
in	O
Xenopus	O
laevis	I:C0043343
oocytes	O
with	O
or	O
without	O
wild	O
-	I:C1883559
type	I:C1883559
GSK3ß	O
or	O
inactive	O
K85RGSK3ß	I:C0244988
.	O

CreaT	O
was	O
expressed	O
in	O
Xenopus	B:C0043343
laevis	I:C0043343
oocytes	O
with	O
or	O
without	O
wild	O
-	I:C1883559
type	I:C1883559
GSK3ß	O
or	O
inactive	O
K85RGSK3ß	I:C0244988
.	O

CreaT	O
was	O
expressed	O
in	O
Xenopus	O
laevis	I:C0043343
oocytes	B:C0029045
with	O
or	O
without	O
wild	O
-	I:C1883559
type	I:C1883559
GSK3ß	O
or	O
inactive	O
K85RGSK3ß	I:C0244988
.	O

CreaT	O
was	O
expressed	O
in	O
Xenopus	O
laevis	I:C0043343
oocytes	O
with	O
or	O
without	O
wild	B:C1883559
-	I:C1883559
type	I:C1883559
GSK3ß	O
or	O
inactive	O
K85RGSK3ß	I:C0244988
.	O

CreaT	O
was	O
expressed	O
in	O
Xenopus	O
laevis	I:C0043343
oocytes	O
with	O
or	O
without	O
wild	O
-	I:C1883559
type	I:C1883559
GSK3ß	B:C0244988
or	O
inactive	O
K85RGSK3ß	I:C0244988
.	O

CreaT	O
was	O
expressed	O
in	O
Xenopus	O
laevis	I:C0043343
oocytes	O
with	O
or	O
without	O
wild	O
-	I:C1883559
type	I:C1883559
GSK3ß	O
or	O
inactive	B:C0244988
K85RGSK3ß	I:C0244988
.	O

CreaT	B:C0215223
and	O
GSK3ß	O
were	O
further	O
expressed	O
without	O
and	O
with	O
additional	O
expression	O
of	O
wild	O
type	I:C1883559
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

CreaT	O
and	O
GSK3ß	B:C0244988
were	O
further	O
expressed	O
without	O
and	O
with	O
additional	O
expression	O
of	O
wild	O
type	I:C1883559
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

CreaT	O
and	O
GSK3ß	O
were	O
further	O
expressed	B:C1171362
without	O
and	O
with	O
additional	O
expression	O
of	O
wild	O
type	I:C1883559
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

CreaT	O
and	O
GSK3ß	O
were	O
further	O
expressed	O
without	O
and	O
with	O
additional	O
expression	B:C1171362
of	O
wild	O
type	I:C1883559
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

CreaT	O
and	O
GSK3ß	O
were	O
further	O
expressed	O
without	O
and	O
with	O
additional	O
expression	O
of	O
wild	B:C1883559
type	I:C1883559
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

CreaT	O
and	O
GSK3ß	O
were	O
further	O
expressed	O
without	O
and	O
with	O
additional	O
expression	O
of	O
wild	O
type	I:C1883559
PKB	B:C0285558
/	I:C0285558
Akt	I:C0285558
.	O

Creatine	B:C1159797
transport	I:C1159797
in	O
those	O
oocytes	O
was	O
quantified	O
utilizing	O
dual	O
electrode	O
voltage	O
clamp	O
.	O

Creatine	O
transport	I:C1159797
in	O
those	O
oocytes	B:C0029045
was	O
quantified	O
utilizing	O
dual	O
electrode	O
voltage	O
clamp	O
.	O

Electrogenic	B:C1159797
creatine	I:C1159797
transport	I:C1159797
was	O
observed	O
in	O
CreaT	O
expressing	O
oocytes	O
but	O
not	O
in	O
water	O
-	O
injected	O
oocytes	O
.	O

Electrogenic	O
creatine	I:C1159797
transport	I:C1159797
was	O
observed	O
in	O
CreaT	B:C0215223
expressing	O
oocytes	O
but	O
not	O
in	O
water	O
-	O
injected	O
oocytes	O
.	O

Electrogenic	O
creatine	I:C1159797
transport	I:C1159797
was	O
observed	O
in	O
CreaT	O
expressing	B:C1171362
oocytes	O
but	O
not	O
in	O
water	O
-	O
injected	O
oocytes	O
.	O

Electrogenic	O
creatine	I:C1159797
transport	I:C1159797
was	O
observed	O
in	O
CreaT	O
expressing	O
oocytes	B:C0029045
but	O
not	O
in	O
water	O
-	O
injected	O
oocytes	O
.	O

Electrogenic	O
creatine	I:C1159797
transport	I:C1159797
was	O
observed	O
in	O
CreaT	O
expressing	O
oocytes	O
but	O
not	O
in	O
water	B:C0043047
-	O
injected	O
oocytes	O
.	O

Electrogenic	O
creatine	I:C1159797
transport	I:C1159797
was	O
observed	O
in	O
CreaT	O
expressing	O
oocytes	O
but	O
not	O
in	O
water	O
-	O
injected	B:C0413385
oocytes	O
.	O

Electrogenic	O
creatine	I:C1159797
transport	I:C1159797
was	O
observed	O
in	O
CreaT	O
expressing	O
oocytes	O
but	O
not	O
in	O
water	O
-	O
injected	O
oocytes	B:C0029045
.	O

In	O
CreaT	B:C0215223
expressing	O
oocytes	O
,	O
co-expression	O
of	O
GSK3	O
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	O
induced	O
current	O
.	O

In	O
CreaT	O
expressing	B:C1171362
oocytes	O
,	O
co-expression	O
of	O
GSK3	O
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	O
induced	O
current	O
.	O

In	O
CreaT	O
expressing	O
oocytes	B:C0029045
,	O
co-expression	O
of	O
GSK3	O
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	O
induced	O
current	O
.	O

In	O
CreaT	O
expressing	O
oocytes	O
,	O
co-expression	B:C1171362
of	O
GSK3	O
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	O
induced	O
current	O
.	O

In	O
CreaT	O
expressing	O
oocytes	O
,	O
co-expression	O
of	O
GSK3	B:C0244988
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	O
induced	O
current	O
.	O

In	O
CreaT	O
expressing	O
oocytes	O
,	O
co-expression	O
of	O
GSK3	O
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	B:C0244988
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	O
induced	O
current	O
.	O

In	O
CreaT	O
expressing	O
oocytes	O
,	O
co-expression	O
of	O
GSK3	O
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	B:C0010286
induced	O
current	O
.	O

In	O
CreaT	O
expressing	O
oocytes	O
,	O
co-expression	O
of	O
GSK3	O
ß	I:C0244988
but	O
not	O
of	O
K85RGSK3ß	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
of	O
creatine	O
induced	O
current	B:C0162585
.	O

Kinetic	O
analysis	B:C0936012
revealed	O
that	O
GSK3ß	O
significantly	O
decreased	O
the	O
maximal	O
creatine	O
transport	O
rate	O
.	O

Kinetic	O
analysis	O
revealed	O
that	O
GSK3ß	B:C0244988
significantly	O
decreased	O
the	O
maximal	O
creatine	O
transport	O
rate	O
.	O

Kinetic	O
analysis	O
revealed	O
that	O
GSK3ß	O
significantly	O
decreased	O
the	O
maximal	O
creatine	B:C0010286
transport	O
rate	O
.	O

Kinetic	O
analysis	O
revealed	O
that	O
GSK3ß	O
significantly	O
decreased	O
the	O
maximal	O
creatine	O
transport	B:C0005528
rate	O
.	O

Exposure	O
of	O
CreaT	B:C0215223
and	O
GSK3ß	O
expressing	O
oocytes	O
for	O
24	O
hours	O
to	O
Lithium	O
was	O
followed	O
by	O
a	O
significant	O
increase	O
of	O
the	O
creatine	O
induced	O
current	O
.	O

Exposure	O
of	O
CreaT	O
and	O
GSK3ß	B:C0244988
expressing	O
oocytes	O
for	O
24	O
hours	O
to	O
Lithium	O
was	O
followed	O
by	O
a	O
significant	O
increase	O
of	O
the	O
creatine	O
induced	O
current	O
.	O

Exposure	O
of	O
CreaT	O
and	O
GSK3ß	O
expressing	B:C1171362
oocytes	O
for	O
24	O
hours	O
to	O
Lithium	O
was	O
followed	O
by	O
a	O
significant	O
increase	O
of	O
the	O
creatine	O
induced	O
current	O
.	O

Exposure	O
of	O
CreaT	O
and	O
GSK3ß	O
expressing	O
oocytes	B:C0029045
for	O
24	O
hours	O
to	O
Lithium	O
was	O
followed	O
by	O
a	O
significant	O
increase	O
of	O
the	O
creatine	O
induced	O
current	O
.	O

Exposure	O
of	O
CreaT	O
and	O
GSK3ß	O
expressing	O
oocytes	O
for	O
24	O
hours	O
to	O
Lithium	B:C0023870
was	O
followed	O
by	O
a	O
significant	O
increase	O
of	O
the	O
creatine	O
induced	O
current	O
.	O

Exposure	O
of	O
CreaT	O
and	O
GSK3ß	O
expressing	O
oocytes	O
for	O
24	O
hours	O
to	O
Lithium	O
was	O
followed	O
by	O
a	O
significant	O
increase	O
of	O
the	O
creatine	B:C0010286
induced	O
current	O
.	O

Exposure	O
of	O
CreaT	O
and	O
GSK3ß	O
expressing	O
oocytes	O
for	O
24	O
hours	O
to	O
Lithium	O
was	O
followed	O
by	O
a	O
significant	O
increase	O
of	O
the	O
creatine	O
induced	O
current	B:C0162585
.	O

The	O
effect	O
of	O
GSK3ß	B:C0244988
on	O
CreaT	O
was	O
abolished	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

The	O
effect	O
of	O
GSK3ß	O
on	O
CreaT	B:C0215223
was	O
abolished	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

The	O
effect	O
of	O
GSK3ß	O
on	O
CreaT	O
was	O
abolished	O
by	O
co-expression	B:C1171362
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

The	O
effect	O
of	O
GSK3ß	O
on	O
CreaT	O
was	O
abolished	O
by	O
co-expression	O
of	O
PKB	B:C0285558
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	B:C0244988
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	O
Lithium	O
and	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	B:C0013081
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	O
Lithium	O
and	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	B:C0215223
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	O
Lithium	O
and	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	B:C0215223
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	O
Lithium	O
and	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	B:C0087111
with	O
the	O
antidepressant	O
Lithium	O
and	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	B:C0003289
Lithium	O
and	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	O
Lithium	B:C0023870
and	O
by	O
co-expression	O
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	O
Lithium	O
and	O
by	O
co-expression	B:C1171362
of	O
PKB	O
/	I:C0285558
Akt	I:C0285558
.	O

GSK3ß	O
down	O
-	I:C0013081
regulates	I:C0013081
the	O
creatine	O
transporter	I:C0215223
CreaT	O
,	O
an	O
effect	O
reversed	O
by	O
treatment	O
with	O
the	O
antidepressant	O
Lithium	O
and	O
by	O
co-expression	O
of	O
PKB	B:C0285558
/	I:C0285558
Akt	I:C0285558
.	O

